Stay updated on CAB-AXL-ADC in Sarcoma Clinical Trial
Sign up to get notified when there's something new on the CAB-AXL-ADC in Sarcoma Clinical Trial page.

Latest updates to the CAB-AXL-ADC in Sarcoma Clinical Trial page
- Check6 days agoChange DetectedPage revision updated from v3.3.1 to v3.3.2; no changes to study details or content are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check13 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check21 days agoChange DetectedDifference0.3%

- Check35 days agoChange DetectedThe study record now shows updated dates (Primary Completion Actual 2025-01-08; Study Completion Actual 2025-01-08) and the latest Last Update Posted date, with enrollment listed as 245 across sites.SummaryDifference0.3%

- Check63 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference4%

- Check71 days agoChange DetectedPage updates reflect a versioned metadata refresh (e.g., Revision: v3.1.0) and date stamps, replacing older items (e.g., Revision: v3.0.2) and removing an outdated resource note. Overall, there is no significant change to core content or critical data.SummaryDifference2%

Stay in the know with updates to CAB-AXL-ADC in Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CAB-AXL-ADC in Sarcoma Clinical Trial page.